Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Heska Confirms Details for Annual Meeting of Stockholders on May 3, 2018

Heska
Posted on: 26 Apr 18

LOVELAND, Colo., April 25, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, confirmed access details for its 2018 Annual Meeting of Stockholders scheduled for 9 a.m. MT/11 a.m. ET on Thursday, May 3, 2018. The meeting will be held at the Westin Denver International Airport. Stockholders of record as of March 15, 2018, are entitled to notice of, and to attend and vote at, the annual meeting.

2018 Annual Meeting of Stockholders
9 a.m. MT/11 a.m. ET
Thursday, May 3, 2018
Westin Denver International Airport

Stockholders unable to attend may access the Annual Meeting via live webcast or telephone.

To access the webcast:

Webcast Access: http://public.viavid.com/index.php?id=129174 
The webcast will also be archived on www.heska.com for 90 days.

To access via telephone:

From within the United States, please dial 1-855-327-6837
From outside of the United States, please dial 1-631-891-4304
Reference Conference ID: 10004592

About Heska

Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") (81%) and Other Vaccines, Pharmaceuticals and Products ("OVP") (19%). CCA includes, primarily for canine and feline use, point of care laboratory testing instruments and supplies under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.